Mechanism of Graves Thyroiditis: Implications for Concepts and Therapy of Autoimmunity

References

• Bottazzo G. E., Pujol-Borrell R., Hanafusa T., Feldmann M. Hypothesis: Role of aberrant HLA-DR expression and antigen presentation in the induction of endocrine autoimmunity. Lancet 1983; 11: 1115–1119
   Google Scholar
• Pujol-Borrell R., Todd I. Inappropriate HLA class II in autoimmunity: is it a primary phenomenon. Endocrine and other organ-oriented autoimmune disorders, D. Doniach, G. E Bottazzo. Balliere's Clinical Immunology and Allergy. 1987; 1: 1–27
   Google Scholar
• Deuss T., Buscema M., Bottazzo G. E., Winkelmann W. Recent aspects of the pathogenesis of endocrine autoimmune disorders in the human: what role does the expression of class II HLA molecules in the endocrine target play?. Klin. Wochenschr 1989; 67: 1117
   Google Scholar
• Feldmann M. Regulation of HLA class II expression and its role in autoimmune diseases. Autoimmunity and Autoimmune Disease. Wiley, Chichester 1987; 88–108, Ciba Foundation Symposium 129
   Google Scholar
• Hanafusa T., Chiovato L., Doniach D., Pujol-Borrell R., Russell C. G., Bottazzo G. F. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 1983; ii: 1111–1115
   Google Scholar
• Jackson R. A., Haynes B. E., Berch W. M. Ia + T cells in new onset Graves' disease. J. Clin. Endocrinol. Metab 1984; 59: 187–190
   PubMed Web of Science ®Google Scholar
• Steeg P., Moore R. N., Johnson H. M., Oppenheim J. J. Regulation of murine macrophage la antigen expression by a lymphokine with immune interferon activity. J. Exp. Med, 156: 1780–1793
   Google Scholar
• Steinman R. M., Inaba K., Schuler G., Witmer M. Stimulation of the immune response: Contributions of dendritic cells. Host Resistance Mechanisms to Infectious Agents, Tumours and Allografts, R. M. Steinman, R. J. North. The Rockefeller University Press, New York 1986; 71–97
   Google Scholar
• Lanzavecchia A. Antigen-specific interactions between T and B cells. Nature (Lond.) 1985; 314–537
   Google Scholar
• Hewitt C. R. A., Feldmann M. Human T cell clones present antigen. J. Immunol 1989; 142: 1429–1436
   Google Scholar
• Germain R. N. The ins and outs of antigen processing and presentation. Nature 1986; 322: 687–689
   PubMed Web of Science ®Google Scholar
• Todd I., Pujol-Borrell R., Hammond L. J., Bottazzo G. E., Feldmann M. Interferon γ induces HLA-DR expression by thyroid epithelium. Clin. Exp. Immunol, 61: 265–273
   Google Scholar
• Weetman A. R., Volkman D. J., Burman K. D., Gerrard T. L., Fauci A. S. The in vitro regulation of human thyrocyte HLA-DR antigen expression. J. Clin. Endocrinol. Metab 1986; 61: 817–824
   Google Scholar
• Kissonerghis M., Grubeck-Loebenstein B., Pirich K., Feldmann M., Londei M. Tumour necrosis factor synergises with gamma interferon on the induction of mRNA for DR alpha chain on thyrocytes from Graves' disease and non toxic goiter. Autoimmunity 1989; 4: 255–266
   Google Scholar
• Todd I., Hammond L. J., James R. F. L., Feldmann M., Bottazzo G. F. Epidermal growth factor and transforming growth factor-alpha suppress HLA class II induction in human thyroid epithelial cells. Immunology 1990; 69: 91–96
   PubMed Web of Science ®Google Scholar
• Todd I., Pujol-Borrell R., Hammond L. J., McNally J. M., Feldmann M., Bottazzo G. F. Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone. Clin. Exp. Immunol 1987; 69: 524–531
   PubMed Web of Science ®Google Scholar
• Gaulton G. N., Stein M. E., Safko B., Stadecker M. J. Direct induction of la antigen on murine thyroid derived epithelial cells by reovirus. J. Immunol 1989; 142: 3821–3825
   Google Scholar
• Ciampolillo A., Marini Y., Mirakian R., Buscema M., Schulz T., Pujol-Borrell R., Bottazzo G. E. Retrovirus-like sequences in Graves' disease: implications for human autoimmunity. Lancet 1989; i: 1096–1100
   Google Scholar
• Londei M., Lamb J. R., Bottazzo G. F., Feldmann M. Epithelial cells expressing aberrant MHC Class II determinants can present antigen to cloned human T cells. Nature 1984; 312: 639–641
   PubMed Web of Science ®Google Scholar
• Londei M., Bottazzo G. F., Feldmann M. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 1985; 228: 85–89
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B., Londei M., Greenall C., Pirich K., Kassal H., Waldhausl W., Feldmann M. Pathogenetic relevance of HLA-class II expressing thyroid follicular cells in non toxic goiter and in Graves' disease. J. Clin. Invest 1988; 81: 1608–1614
   PubMed Web of Science ®Google Scholar
• Feldmann M., Londei M., Buchan G. Interferons and autoimmunity. Interferon. Academic Press, London 1987; 75–90
   Google Scholar
• Dayan C. M., Londei M., Corcoran A. E., Grubeck-Loebenstein B., James R. F. L., Rapoport B., Feldmann M. Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc. Natl. Acad. Sci. USA 1991; 88: 7415–7419
   PubMed Web of Science ®Google Scholar
• Charreire J., Michel-Bechet M. Syngeneic sensitisation of mouse lymphocytes on monolayers of thyroid epithelial cells III: induction of thyroiditis by thyroid sensitised lymphoblasts. Eur. J. Immunol 1982; 12: 421–425
   Google Scholar
• Mackenzie W. A., Davies T. F. An intrathyroidal T-Cell clone specifically cytotoxic for human thyroid cells. Immunology, 61: 101–103
   Google Scholar
• Davies T. E. Coculmre of human thyroid mono layer cells and autologous T cells: input of HLA class II expression. J. Clin. Endocrinol. Metab 1985; 61: 418–422
   PubMed Web of Science ®Google Scholar
• Czirjak L., Danko K., Gaulton G. N., Stadecker M. J. Thyroid derived epithelial cells acquire alloantigen presenting capacity following irradiation and class II antigen induction. Eur. J. Immunol 1990; 210: 2597–2601
   Google Scholar
• del Prete G. E., Tiri A., Marriotti S., Pinchera A., Ricci M., Romagnani S. Enhanced produclion of γ-interferon by thyroid derived T cell clones from patients with Hashimoto's thyroiditis. Clin. Exp. Immunol 1987; 69: 323
   PubMed Web of Science ®Google Scholar
• Londei M., Savill C., Verhoef A., Brennan E., Leech Z. A., Duance V., Maini R. N., Feldmann M. Persistence of collagen type II specific T cell clones in the synovial membrane of a patient with RA. Proc. Natl. Acad. Sci 1989; 86: 636–640
   PubMed Web of Science ®Google Scholar
• Olsson T., Zhi W. W., Hojeberg B., Kostulas V., Yu-Ping J., Anderson G., Ekre H -P, Link H. Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of interferon-gamma. J. Clin. Invest 1990; 86: 981–985
   PubMed Web of Science ®Google Scholar
• Hohlfeld R., Toyka K. V., Heiniger K., Grosse-Wilde H., Kalies I. Autoimmune human T-lympho-cytes specific for acetylcholine receptor. Nature 1984; 310: 244–245
   PubMed Web of Science ®Google Scholar
• De Berardinis P., Londei M., James R. F. L., Lake S. R., Wise P. H., Feldmann M. Do CD4+ cytotoxic T cells damage islet b cells in type I diabetes?. Lancet 1988; ii: 823–824
   Google Scholar
• Burman P., Totterman T. H., Oberg K., Karisson F. A. Thyroid autoimmunity in patients on long term therapy with leukocyte-drived interferon. J. Clin. Endocrinol. Metab 1986; 63: 1086–1090
   PubMed Web of Science ®Google Scholar
• Fentiman I. S., Thomas B. S., Balkwill F. R., Rubens R. D., Hayward J. L. Primary hypothyroidism associated with inteferon therapy of breast cancer (letter). Lancet 1985; i: 1166–1170
   Google Scholar
• Atkins M. B., Mier J. W., Parkinson D. R., Gould J. A., Berkman E. M., Kaplan M. M. Hypothyroidism after treatment with interleukin 2 and lymphokine-activated killer cells. N. Engl. J. Med 1988; 318: 1557–1563
   PubMed Web of Science ®Google Scholar
• Lavelle-Jones M., Al-Hadrani A., Spiers E. M., Campbell F. C., Cuschieri A. Reactivation of rheumatoid arthritis during continuous infusion of interleukin 2: evidence of lymphocytic control of rheumatoid disease. Brit. Med. J 1990; 301: 97
   Google Scholar
• Halloran P. E., Urmson J., Van der Meide P H., Antenfried P. Regulation of MHC expression in vivo II IFNαβ induces and recombinant IFNα modulate MHC expression in mouse tissues. J. Immunol 1989; 142: 4241–4247
   PubMed Web of Science ®Google Scholar
• Rhodes J., Jones D. H., Bleehen N. M. Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo. Clin. Exp. Immunol 1983; 53: 739–743
   PubMed Web of Science ®Google Scholar
• Feldmann M., Brennan F. M., Chantry D., Haworth C., Turner M., Katsikis R., Londei M., Abney E., Buchan G., Barrett K., Corcoran A., Kissonerghis M., Zheng R., Grubeck-Loebenstein B., Barkley D., Chu A., Field M., Maini R. N. Cytokine assays: Role in evaluation of the pathogenesis of autoimmunity. Immunological Reviews 1991; 119: 105–123
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B., Buchan G., Chantry D., Kassal H., Londei M., Pirich K., Barrett K., Turner M., Waldhausl W., Feldmann M. Analysis of intrathyroidal cytokine production in thryoid autoimmune disease: thyroid follicular cells produce IL-1α and interleukin-6. Clin. Exp. Immunol 1989; 77: 324–330
   PubMed Web of Science ®Google Scholar
• Hamilton E., Black M., Farquharson M., Stewart C., Foulis M. C. Correlation between thyroid epithelial cells expressing class II MHC molecules and interferonγ containing lymphocytes in human thyroid autoimmune disease. Clin. Exp. Immunol 1988; 83: 64–68
   Google Scholar
• Austin P., Trowsdale J., Rudd C., Bodmer W., Feldmann M., Lamb J. R. Functional expression of HLA-DP genes transfected into mouse fibroblasts. Nature 1985; 313: 61–64
   PubMedGoogle Scholar
• Altmann D. M., Hogg N., Trowsdale J., Wilkinson D. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature 1989; 338: 512–514
   PubMed Web of Science ®Google Scholar
• Zheng R. Q. H., Abney E. R., Grubeck-Loebenstein B., Dayan C., Maini R. N., Feldmann M. Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3 on human thyroid epithelial cells in Graves' and Hashimoto's diseases. J. Autoimmunity 1990; 3: 727–736
   PubMed Web of Science ®Google Scholar
• Feldmann M., Dayan C., Rapoport B., Londei M. T cell activation and antigen presentation in human thyroid autoimmunity. J. Autoimmunity 1992; 5(Suppl. A)115–121
   PubMedGoogle Scholar
• Zheng R. Q. H., Abney E., Chu C. Q., Field M., Grubeck-Loebenstein B., Maini R. N., Feldmann M. Detection of IL-6 and IL-1 production in human thyroid epithelial cells by non-radioactive in situ hybridization and immunohistochemical methods. Clin. Exp. Immunol 1991; 83: 314–319
   PubMedGoogle Scholar
• Sarvetnick N. D., Liggitt S. L., Pitts S. E., Hansen S. E., Stewart T. A. Insulin dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon γ. Cell 1988; 52: 773–782
   PubMed Web of Science ®Google Scholar
• Allison J., Campbell I. L., Morahan G., Mandel T. E., Harrison L. C., Miller J. F. A. R. Diabetes in transgenic mice resulting from over-expression of class I histocompatability molecules in pancreatic β cells. Nature 1988; 333: 529–533
   PubMed Web of Science ®Google Scholar
• Lo D., Burkly G., Widera C., Cowing R. A., Flavell R. D., Palmiter R. D., Brinster R. L. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 1988; 53: 159–168
   PubMed Web of Science ®Google Scholar
• Bohme J., Haskins K., Stecha R., van Ewijk W., LeMeur P., Gerlinger C., Benoist C., Mathis D. Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant. Science 1989; 244: 1179–1183
   PubMed Web of Science ®Google Scholar
• Burkly L. C., Lo D., Kanagawa O., Brinster R. L., Flavell R. A. T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E. Nature 1989; 342: 564–566
   PubMed Web of Science ®Google Scholar
• Sarvetnick J., Shirzuru J., Liggitt D., Martin L., McIntyre A., Gregory A., Parslow T., Stewart T. Loss of pancreatic islet cell tolerance induced by β-cell expression of interferon-γ. Nature 1990; 346: 844–847
   PubMed Web of Science ®Google Scholar
• Foulis A. K., Farquharson M. A., Hardman R. Aberrant expression of class II major histocompatibility complex molecules by β cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-diabetes) mellitus. Diabetol 1987; 30: 333–343
   PubMed Web of Science ®Google Scholar
• Dean B. M., Walker R., Bone A. J., Baird J. D., Cooke A. Pre-diabetes in the spontaneously diabetic BB rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells. Diabetol 1985; 28: 464–466
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B., Kassal H., Smyth P. P. A., Krisch K., Waldhäual. The prevalance of immunological abnormalities in endemic simple goitre. Acta Endocrinologica (Copenh) 1986; 113: 508–513
   Google Scholar
• Lloyd R. V., Johnson T. L., Blaivias M., Sisson Sisson J.C., Wilson B. S. Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody. Am. J. Pathol 1985; 120: 106–111
   Google Scholar
• Peters P. J., Neefjes J. J., Oorschot V., Ploegh H. L., Geuze H. J. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 1991; 349: 669–676
   PubMed Web of Science ®Google Scholar
• Rudensky A., Preston-Hurlbert P., Hong S. C., Barlow A., Janeway C. A. Sequence analysis of peptides bound to MHC class II. Nature 1991; 353: 622–627
   PubMed Web of Science ®Google Scholar
• Weiss S., Bogen B. MHC class II restricted presentation of intracellular antigen. Cell 1991; 64: 767–776
   PubMed Web of Science ®Google Scholar
• Nuchtern J. G., Biddison W. E., Klausner R. D. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 1990; 343: 74–76
   PubMed Web of Science ®Google Scholar
• Jaraquemada D., Marti M., Long E. O. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class H-restricted T cells. J. Exp. Med 1990; 172: 947–954
   PubMedGoogle Scholar
• Hermann E., Lohse A. W., VanderZee R., Van Eden W., Mayet W. J., Probst P., Poralla X., Meyer zum Buschentelde K., Fleischer B. Synovial fluid-derived Yersinia-reactive T cells responding to human 65-kDa heat-shock protein and heat stressed antigen-presenting cells. Eur. J. Immunol 1991; 21: 2139–2143
   PubMed Web of Science ®Google Scholar
• Frohman M., Francfort J. W., Cowing C. T-dependent destruction of thyroid isografts exposted to IFN-γ. J. Immunol 1991; 146: 2227–2234
   PubMed Web of Science ®Google Scholar
• Champion B. R., Page K. R., Parish N., Rayner D. C., Dawe K., Biswas-Hughes G., Cooke A., Geysen M., Roitt I. M. Identification of a thyroxine-containing self epitope of thyroglobulin which triggers thyroid autoreactive T cells. J. Exp. Med 1991; 174: 363–370
   PubMed Web of Science ®Google Scholar
• Bland P. W., Warren L. G. Antigen presentation by epithelial cells of the rat small intestine. Immunol 1986; 58: 1–7
   PubMed Web of Science ®Google Scholar
• Lamb J. R., Skidmore B. J., Green N., Chiller J. M., Feldmann M. Induction of tolerance in Influenza virus immune T lymphocyte clones with synthetic peptides of Influenza haemagglutinin. J. Exp. Med 1983; 157: 1434–1447
   PubMed Web of Science ®Google Scholar
• Dayan C. M., Londei M., Knyba R., Rapoport B., Feldmann M. T cells involved in human autoimmune disease are resistant to tolerance induction. 1992, in preparation
   Google Scholar
• O'Hehir R., Lamb J. R. Induction of specific clonal anergy in human T lymphocytes by staphylococal aureus enterotoxins. PNAS 1991; 87: 8884–8888
   Google Scholar
• Weetman A. R., Volkman D. J., Burman K. D., Margolick J. B., Petrick E., Weintraub B. D., Fauci A. S. The production and characterisation of thyroid-derived T cell lines in Graves' disease and Hashimoto's thyroiditis. Clin. Immunol. Immunopathol 1986; 39: 139–150
   PubMedGoogle Scholar
• Del Prete G. E., Mariotti S., Tiri A., Ricci M., Pinchera A., Romagnani S. Characterisation of thyroid infiltrating lymphocytes in Hashimoto's thyroiditis. Acta Endocrinol (Copenh) Suppl 1987; 281: 111–115
   Google Scholar
• MacKenzie W. A., Schwartz A. E., Friedman E. W., Davies T. F. Intrathyroidal T cell clones from patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab 1987; 64: 818–824
   PubMed Web of Science ®Google Scholar
• Van Oers M. H. J., Pinkster J., Zeijlemaker W. R. Quantification of antigen-reactive cells among human lymphocytes. Eur. J. Immunol 1978; 8: 477–484
   PubMed Web of Science ®Google Scholar
• Tandon N., Zhang L., Weetman A. P. HLA associations with Hashimoto's disease. Clin. Endocrinol. (Oxf.) 1991; 34: 383–386
   PubMed Web of Science ®Google Scholar
• Kimura H., Davies T. F. Thyroid-specific T cells in normal Wistar rats IIT cell clones interact with cloned Wistar rat thyroid cells and provide evidence of autoantigen presentation by thyroid epithelial cells. Clin. Immunol. Immunopathol 1991; 58: 195–206
   PubMedGoogle Scholar
• Wraith D. C., McDevitt H. O., Steinman L., Acha-Orbea H. T cell recognition as the target for immune intervention in autoimmune disease. Cell 1989; 57: 709–715
   PubMed Web of Science ®Google Scholar